StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Celgene (CELG) PT Lowered to $117 at BofA/Merrill Lynch Following Juno (JUNO) Acquisition
January 22, 2018 11:12 AM
BofA/Merrill Lynch lowered its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Notable Call Buying Activity Continues in Celgene (CELG) Following Reported Acquisition of Juno Therapeutics (JUNO) -Susquehanna
January 23, 2018 1:41 PM
Celgene (CELG) to Acquire Juno Therapeutics (JUNO) for $87/Share
January 22, 2018 6:30 AM
